The 2nd Gen mTOR Inhibitor INK128 Overcomes Resistance to Everolimus (1st Gen) in Pancreatic Neuroendocrine Tumors

Wang Yucheng; Hann Byron; VanBrocklin Henry; Shokat Kevan; Warren Robert; Donner David; Bergsland Emily; Nakakura Eric

首页> 外文期刊>Pancreas >The 2nd Gen mTOR Inhibitor INK128 Overcomes Resistance to Everolimus (1st Gen) in Pancreatic Neuroendocrine Tumors

【24h】

The 2nd Gen mTOR Inhibitor INK128 Overcomes Resistance to Everolimus (1st Gen) in Pancreatic Neuroendocrine Tumors

机译：第2族MTOR抑制剂油墨128克服对胰腺神经内分泌肿瘤的抗血管血症（第1 Gen）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pancreas》 |2017年第3期|共1页
作者
Wang Yucheng; Hann Byron; VanBrocklin Henry; Shokat Kevan; Warren Robert; Donner David; Bergsland Emily; Nakakura Eric;
展开▼
作者单位

UCSF San Francisco CA USA;

UCSF San Francisco CA USA;

UCSF San Francisco CA USA;

UCSF San Francisco CA USA;

UCSF San Francisco CA USA;

UCSF San Francisco CA USA;

UCSF San Francisco CA USA;

UCSF San Francisco CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. The 2nd Gen mTOR Inhibitor INK128 Overcomes Resistance to Everolimus (1st Gen) in Pancreatic Neuroendocrine Tumors [J] . Wang Yucheng, Hann Byron, VanBrocklin Henry, Pancreas . 2017,第3期

机译：第2族MTOR抑制剂油墨128克服对胰腺神经内分泌肿瘤的抗血管血症（第1 Gen）
2. Henrietta Westman . V?gen till Vincent (The Road to Vincent) , 1st edn. Mondial , Stockholm, Sweden , 2019 . 333 pages. ISBN: 978‐91‐88671‐93‐6. Price. 259 SEK (25 €). Hardback. Henrietta Westman Henrietta Henrietta Westman Westman . V?gen till Vincent (The Road to Vincent) V?gen till Vincent (The Road to Vincent) , 1st 1st edn. Mondial Mondial , Stockholm, Sweden Stockholm, Sweden , 2019 2019 . 333 333 pages. ISBN: 978‐91‐88671‐93‐6. Price. 259 SEK (25 €). Hardback. [J] . Acharya Ganesh Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi . 2019,第5期

机译：Henrietta Westman。 v？Gen直到文森特（路上的道路），第一个Edn。 Mondial，斯德哥尔摩，瑞典，2019年。 333页。 ISBN：978-91-88671-93-6。价钱。 259瑞典克朗（25欧元）。精装。 Henrietta Westman Henrietta Henrietta Westman Westman。 v？ten to vincent（路边的道路）v？gen到Vincent（路边的道路），第1 redn。 Mondial Mondial，斯德哥尔摩，瑞典斯德哥尔摩，瑞典，2019年2019年。 333 333页。 ISBN：978-91-88671-93-6。价钱。 259瑞典克朗（25欧元）。精装。
3. A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms [J] . Edward Wolin, Alain Mita, Amit Mahipal, PLoS One . 2019,第9期

机译：用于具有或不含类癌症状的非胰腺神经内分泌肿瘤的口腔MTORC1 / mTORC2激酶抑制剂（CC-223）的2阶段研究
4. Latest 3rd GEN AHSS and 2nd GEN Press Hardened Steels: solutions to new automotive challenges [C] . Henri GUYON International Conference and Exhibition of SIA Multi-Material . 2019

机译：最新的3RD Gen AHSS和第2 Gen Press Hardened Steels：新的汽车挑战解决方案
5. Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-Clinical Mechanistic Assessment [D] . Moorthy, Ganesh P. 2015

机译：BEZ235，PI3K / mTOR抑制剂和依维莫司，mTOR抑制剂的新型组合的临床药代动力学：I期临床研究和非临床机制评估
6. Brivanib a dual FGF/VEGF inhibitor is active both 1st and 2nd line against mouse pancreatic neuroendocrine tumors (PNET) developing adaptive/evasive resistance to VEGF inhibition [O] . Elizabeth Allen, Ian B. Walters, Douglas Hanahan -1

机译：Brivanib双FGF / VEGF抑制剂它是活性既第一和针对小鼠胰腺神经内分泌肿瘤第二线（pNET）显影自适应/回避对VEGF抑制的抗性
7. Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors [O] . Vandamme, T., Beyens, M. (Matthias), de Beeck, K.O. (Ken Op), 2016

机译：新型PI3K-AKT-mTOR抑制剂可克服胰腺神经内分泌肿瘤中长期获得性依维莫司耐药

The 2nd Gen mTOR Inhibitor INK128 Overcomes Resistance to Everolimus (1st Gen) in Pancreatic Neuroendocrine Tumors

著录项

相似文献

相关主题

期刊订阅